Intracorneal implants for the correction of refractive errors and ectatic corneal diseases can be grouped into 2 categories: (1) intracorneal ring segments (ICRS) of up to 355 degree arc length such as the Ferrara ring (Ferrara Ophthalmics, Brazil), Intacs (Addition Technology Inc, Lombard, IL), and Keraring (Mediphacos, Brazil)[@R1]--[@R5] and (2) the intracorneal continuous complete ring MyoRing (Dioptex GmbH, Austria)[@R6],[@R7] (Fig. [1](#F1){ref-type="fig"}). The fundamental mechanism of action behind all these devices is characterized by an arc-shortening effect within the cornea because of the added implant volume to the cornea. While ICRS are implanted into a circular tunnel, the MyoRing is implanted into a corneal pocket through a small corneal incision. Intracorneal ring implants mainly produce deformation of the cornea according to the refractive need. Understanding the biomechanical interaction between intracorneal ring implants and the cornea is therefore important.

![A, The MyoRing is a full ring implant without discontinuity along the entire circumference where the force F required to separate 2 parts of the implant is extremely high. The endings of (B) intra corneal ring segments (ICRS) and (C) incomplete rings can be separated easily by a force F of virtually zero.](cornea-34-1493-g001){#F1}

MATERIALS AND METHODS {#s1}
=====================

The Spherical Dome Model after Daxer[@R8]is an effective and easy-to-use mathematical model of the cornea, which considers (1) the structural and biomechanical heterogeneity of the tunica of the eye, allowing to distinguish between the cornea, limbus, and sclera, as well as (2) the anisotropy and asphericity of the cornea. It therefore facilitates an independent biomechanical analysis of the cornea. Here, σ represents the stress inside the cornea, ρ the isotropically acting intraocular pressure, D the diameter of the cornea (limbus), d the thickness of the cornea, and f is an anisotropy factor ranging between 0 and 1.

In the nonexisting case of structural and biomechanical isotropy within the corneal tissue, when ,with α representing the opening angle of the cornea, and r the corneal radius, the spherical dome model[@R8] converges to the special case of the elastic sphere model after Laplace,[@R9] which is an excellent proof of the model.

In this study, I used the spherical dome model with an appropriate anisotropy factor of f = 1, which results in

An anisotropy factor of f = 1 means that the corneal local cross-sectional area contributes entirely to the stress uptake inside the tissue and not only the projection area into the direction of the resulting force vector, which is aligned roughly in the direction of the optical axis. This is equivalent to an increased strength of the cornea because of the reinforcement in the lamellar direction by the collagen fibrils.[@R10]

The spherical dome model is also based on the fact that the Young modulus of the limbus is reported to be up to 13 MPa, and thus comparatively higher than the Young modulus of the cornea of roughly 0.3 MPa, which allows us to consider the limbus as a biomechanical border of the cornea.[@R8],[@R11]--[@R14]

The corneal implants investigated in this study are made of types of PMMA. PMMA has a Young modulus between 1800 MPa and 3100 MPa, which is even higher than that of the limbus.[@R15] The different implant designs can, however, significantly affect the way in which the comparatively high Young modulus of the material of the implants can be used to stabilize the cornea. The difference in the biomechanical effect of the different implant designs result from whether or not the implant has discontinuity along the circumference or not. This quality determines whether the implant can be considered an additional (artificial) limbus or not. In the case of no discontinuity (MyoRing) the implant can use the enormous Young modulus and act as an additional (artificial) limbus inside the cornea. Accordingly, the postoperative value for D in [Equation 2](#M2){ref-type="disp-formula"} is represented by the inner diameter of the MyoRing DMRI and by the corneal diameter D~c~ preoperatively. In the case of ICRS and incomplete rings, both the preoperative and postoperative value for D in [Equation 2](#M2){ref-type="disp-formula"} is represented by the anatomical corneal diameter D~c~.

This allows the calculation of a strengthening factor sf, which is identical to the term "relative corneal strength" used throughout this study, and which is defined as the ratio between the intracorneal stress before and after treatment according to

The intracorneal stress σ is calculated using [Equation 2](#M2){ref-type="disp-formula"}.

RESULTS {#s2}
=======

MyoRing {#s2-1}
-------

Because every part of the implant is connected to the adjoining part with the full mechanical strength of the material along the entire circumference (Fig. [1](#F1){ref-type="fig"}A), the MyoRing can be biomechanically considered as a further (artificial) limbus, which separates the load on the cornea resulting from the intraocular pressure into an independent load inside the inner diameter of the implant and an independent load between the outer diameter of the implant and the limbus (corneal diameter). Therefore, D in [Equation 2](#M2){ref-type="disp-formula"} is the diameter of the cornea preoperatively (D~c~) and the inner diameter of the MyoRing DMRI (artificial limbus) postoperatively. The corneal strengthening factor sfc of the central cornea is, therefore

Figure [2](#F2){ref-type="fig"}A shows sfc for different corneal diameters and implant geometries.

![A, Corneal strengthening factor for the central corneal area (centrally to the MyoRing) of different MyoRing diameters as a function of the corneal diameter. B, Corneal strengthening factor for the peripheral corneal area (outside the MyoRing) of different MyoRing diameters as a function of the corneal diameter.](cornea-34-1493-g006){#F2}

For the corneal periphery outside the MyoRing (ie, between MyoRing and limbus), the corneal strengthening factor is given bywhere DMRA is the outer MyoRing diameter (Fig. [2](#F2){ref-type="fig"}B).

The peripheral area is, however, not the sensitive area in corneal refractive surgery and in ectatic corneal diseases (Fig. [3](#F3){ref-type="fig"}). Therefore, the relevant corneal strengthening factor is sf = sfc.

![Cornea with a 5-mm MyoRing. The arrows indicate the stress vector components within the cornea for a 5-mm MyoRing (left) and a 7-mm MyoRing (right). The true stress vector runs tangentially to local corneal curvature at the position of the implant. The horizontal vectors indicate the component of the intracorneal stress acting within the implant plane, which is the effective plane to take up the intracorneal stress.](cornea-34-1493-g008){#F3}

As a result, the cornea is strengthened by a factor of 3.0 with a 5-mm MyoRing, by a factor of 2.4 with a 6-mm MyoRing and by a factor of 2.0 with a 7-mm MyoRing, using a corneal diameter of 12 mm in [Equation 2](#M2){ref-type="disp-formula"} (Fig. [2](#F2){ref-type="fig"}A). The inner diameter of the MyoRing is 1 mm less than the outer one.

As long as the lamellar incision for the insertion of the implant is small, it is not expected to contribute significantly to the biomechanical modification of the tissue.[@R7] It is, therefore, important to remain significantly below an opening angle of 45 degrees when creating a 9-mm pocket at 300-μm depth. The opening width w therefore has to be less than 5.5 mm. In no case should the outer diameter of the MyoRing rest beyond the connection line w between the 2 opposite incision limits. Therefore, the incision width w should meet the following 3 criteria to guarantee an unaltered strength of the corneal tissue (Fig. [4](#F4){ref-type="fig"}): Range 1: w ≤ DMRA and w \< 5.5 mm; range 2: w ≤ D~p~·sin(arccos(DMRA/D~p~)), where D~p~ is the diameter of the pocket of 9 mm, and DMRA is the outer diameter of the MyoRing.

![Pocket incision width w as a function of the MyoRing diameter. The area with horizontal lines is the range of safe application.](cornea-34-1493-g009){#F4}

ICRS AND INCOMPLETE RINGS {#s3}
=========================

The situation is totally different when considering incomplete ring geometry such as in ICRS. Virtually no force is required to separate the endings (Figs. [1](#F1){ref-type="fig"}B, C). In such a case, the implant cannot act as an artificial limbus to stabilize the cornea. D in [Equation 2](#M2){ref-type="disp-formula"} is, therefore, represented by the real anatomical corneal diameter preoperatively and postoperatively, which results in a constant strengthening factor of sf = 1. Consequently, ICRS and incomplete rings have no strengthening effect on the cornea whatsoever.

DISCUSSION {#s4}
==========

Various reports suggest that MyoRing implantation in keratoconic corneas can not only achieve visual rehabilitation but also perhaps stop the progression of the disease.[@R16]--[@R18] In contrast to the clinical data obtained after MyoRing implantation for keratoconus, the clinical data after ICRS implantation do not indicate stopping disease progression.[@R19],[@R20] So far, only corneal cross-linking (CXL) has been shown to stop progression of the disease, yet without achieving visual rehabilitation.[@R21]--[@R23] The strengthening factor of CXL in humans was reported to be approximately 4.5.[@R24]

PMMA is characterized by a comparatively high Young modulus ("stiffness") that can be used by the MyoRing but not by the ICRS. In this respect, Figure [1](#F1){ref-type="fig"} and Figure [3](#F3){ref-type="fig"} relate these characteristics to the mechanism responsible for stabilization (strengthening) of the cornea by the MyoRing.

Although the strengthening of the cornea in CXL is achieved on an ultrastructural level resulting in a stiffening of the tissue by increasing the Young modulus, the mechanism of strengthening the cornea by means of MyoRing insertion is different. A cornea treated by MyoRing implantation can be compared to a load-bearing ceiling beam that evenly distributes the load resting on the ceiling over 2 separate compartments, each of which requires only partial strength to take up the load. An interrupted ceiling beam, which is equivalent to ring segments, is unable to fulfill this function.

A comparison of different refractive procedures with respect to the strengthening factor is shown in Figure [5](#F5){ref-type="fig"}. ICRS treatment including incomplete rings is biomechanically neutral as long as the radial cut is sutured. MyoRing treatment strengthens the cornea considerably. It is therefore possible to combine MyoRing treatment with excimer laser surface ablation without biomechanically harming the cornea.[@R25] However, it is no longer necessary to combine MyoRing treatment with CXL in progressive keratoconus[@R26],[@R27] because MyoRing implantation alone seems to be sufficient to strengthen the cornea. In contrast to early experiments on complete rings,[@R28] the design of the MyoRing combines 2 a priori conflicting qualities in one device: it is rigid enough to modify and stabilize the corneal shape according to the refractive needs, and flexible with a shape memory to allow quick, easy, and reversible implantation into the corneal pocket through a small entrance.[@R7] The model presented in [Equations 1 and 2](#M1 M2){ref-type="disp-formula"} draws on an anisotropic cornea.[@R8]

![Postoperative relative corneal strength (black bars) compared with preoperative relative corneal strength (white bars) for different refractive treatments. A postoperative value of less than 1 means weakening of the cornea, whereas a value higher than 1 means strengthening. For the laser treatments, −7.75 D correction according to a case presented in the model of Reinstein et al[@R29] was used. The MyoRing case assumes a 6-mm MyoRing (outer diameter) and a corneal diameter of 12 mm. The strengthening factor for CXL was taken from experiments performed by Wollensak et al.[@R24]](cornea-34-1493-g010){#F5}

Mathematically speaking, choosing f = 1 in the basic equation ([Eq. 1](#M1){ref-type="disp-formula"}) for the lamellar cornea is equivalent to biomechanical domination of the lamellar direction within a stiffness tensor (stress tensor) applied to the cornea. It is unimportant for the resulting stress σ in [Equation 1](#M1){ref-type="disp-formula"} whether the relative strengthening (reduced σ) in the lamellar direction is mathematically achieved by an increased Young modulus in the lamellar direction within the stress tensor or by an increase in the related cross-sectional area (f = 1).

The fact that the model[@R8] converges to the law of Laplace[@R9] in the special case of an isotropic assumption and that the results for laser vision correction are in excellent agreement with other models[@R29] indicates that the model is valid.

The assumption of a depth-dependent Young modulus may have an impact on the corneal biomechanics after tissue-removing refractive procedures,[@R29] but not when considering corneal ring implants in which case the relative composition of the corneal tissue remains unchanged.

The model presented is an approximation and does not incorporate higher-order effects. Such higher-order effects may result from nonlinearity of the stress--strain relation of the tissue. Because it is assumed that the preoperative intraocular pressure corresponds to the postoperative one and the cornea is not exposed to a dynamic load, the presented results should not be sensitive to this effect.

The true stress vector within the tissue is represented by the tangential arrows in Figure [3](#F3){ref-type="fig"}. The MyoRing is, however, only able to take up the component acting within the plane of the implant according to Figure [1](#F1){ref-type="fig"}A, which is represented by the horizontal arrows in Figure [3](#F3){ref-type="fig"}. This modifies the strengthening factor, however, only minimally: from 3.0 to 2.95 for a 5-mm implant and from 2.0 to 1.88 for a 7-mm implant.

Sophisticated numerical approaches to simulate corneal biomechanics are laborious and applicable to specific problems only.[@R30],[@R31] There are also no valuable measurement techniques and trustable biomechanical parameters of the human cornea.[@R11]--[@R14],[@R30],[@R31] Therefore, even "sophisticated computational methods" are burdened with related uncertainties. The results in this study are relative values obtained from 2 different states (preoperatively and postoperatively) to reduce such uncertainties.

Long-term studies on MyoRing treatment are currently being conducted to clinically prove the presented theory.
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